FeaturesSignalPricingFounders
Log inGet started free
BC

Bay City Capital

Venture CapitalActive

Bay City Capital LLC (Bay City Capital), established in 1997 , specializes in investments in the life sciences industry.

San Francisco, United StatesFounded 1997baycitycapital.com/
98
Investments
9
Exits
$1.5B
AUM
9.2%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Bay City Capital.

Get started free

Investment Thesis & Strategy

Bay City Capital invests in various stages of life sciences companies, focusing on the biotech industry. They look for companies with promising innovations in the life sciences sector.

Investment Activity

Deals per year over the last 8 years

2
2001
2
2002
0
2003
0
2004
1
2005
1
2006
1
2007
1
2008

Portfolio Companies

Selected investments from their portfolio of 98 companies

N
Neurocrine Biosciences
Biotech · Series A, 0
Active
R
Regeneron Pharmaceuticals
Biotech · Series A, 0
Active
O
Onyx Pharmaceuticals
Biotech · Series A, 0
Active
N
Nektar Therapeutics
Biotech · Series A, 0
Active
E
Esperion Therapeutics
Biotech · Series A, 2008
Active
C
Catalent Pharma Solutions
Biotech · Growth, 2007
Active
P
Pharmacyclics
Biotech · Series A, 2006
Active
P
Portola Pharmaceuticals
Biotech · Series A, 2005
Active
I
Intra-Cellular Therapies
Biotech · Series A, 2002
Active
A
Alnylam Pharmaceuticals
Biotech · Series A, 2002
Active
S
Seattle Genetics
Biotech · Series A, 2001
Active
A
Amicus Therapeutics
Biotech · Series A, 2001
Active

Notable Exits

CompanyTypeYearValue / Acquirer
MedivationAcquisition2016$14B
PharmacyclicsAcquisition2015$21B
Esperion TherapeuticsIPO2013—
Onyx PharmaceuticalsAcquisition2013$10.4B
Amicus TherapeuticsIPO2013—
Portola PharmaceuticalsIPO2013$1.1B
Alnylam PharmaceuticalsIPO2004—
Neurocrine BiosciencesIPO2004—
Seattle GeneticsIPO2001—

Frequently Asked Questions

Bay City Capital focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Index Ventures

San Francisco, United States · 827 deals

First Round Capital

San Francisco, United States · 742 deals

Benchmark

San Francisco, United States · 600 deals

Founders Fund

San Francisco, United States · 564 deals

Matrix Partners

San Francisco, United States · 549 deals

Bain Capital Ventures

San Francisco, United States · 438 deals